Larvol Delta - Vosoritide-safety-and-effectiveness-in-young-children-with-achondroplasia-aged-3-years-and-with-up-to-36-months-of-followup-from-the-Japanese-postmarketing-safety-surveillance-study-111604

Voxzogo (vosoritide) - BioMarin

https://pag.virtual-meeting.org/RELEASE/espe2026/en-GB/pag/presentation/749549

MD; PhD Kenichi Kashimada

Sep 5, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next